The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ARB: Phase II window of opportunity study of short-term preoperative treatment with enzalutamide in ER-positive and triple-negative breast cancer.
 
Peter Schmid
Honoraria - AstraZeneca; Pfizer
Consulting or Advisory Role - Roche/Genentech
Research Funding - Astellas Pharma; AstraZeneca; Genentech; OncoGenex
 
Duncan A Wheatley
Honoraria - Novartis; Roche
Speakers' Bureau - Roche
 
Alastair Mark Thompson
No Relationships to Disclose
 
Pankaj Roy
Consulting or Advisory Role - Genomic Health
 
Nigel J Bundred
Speakers' Bureau - Genomic Health
 
Anand David Purushotham
No Relationships to Disclose
 
Stuart McINTOSH
No Relationships to Disclose
 
Sherko Kummel
Honoraria - Amgen; Celgene; Genomic Health; Novartis; Roche
Consulting or Advisory Role - Roche
Research Funding - Roche
Travel, Accommodations, Expenses - Celgene; Roche
 
Nadia Harbeck
No Relationships to Disclose
 
Ulrike Nitz
No Relationships to Disclose
 
David Barnes
No Relationships to Disclose
 
Shah-Jalal Sarker
No Relationships to Disclose
 
Kelly Mousa
No Relationships to Disclose
 
Javier Cortes
Stock and Other Ownership Interests - MedSIR
Honoraria - Celgene; Eisai; Novartis; Roche/Genentech
Consulting or Advisory Role - Celgene; Roche/Genentech